Fed and Fasted Administration of a Novel Extended‐Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|7|2|160-167

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.7, Iss.2, 2018-02, pp. : 160-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

The mirtazapine orally disintegrating tablet (ODT) has a faster onset of action than extended-release (XR) venlafaxine

By  

Inpharma, Vol. 1, Iss. 1532, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

An extended-release formulation of desferrioxamine for subcutaneous administration

By Toliyat Tayebeh   Jorjani Masomeh   Khorasanirad Zeinab  

Drug Delivery, Vol. 16, Iss. 7, 2009-10 ,pp. : 416-421

Informa Healthcare

Access to resources Recommend Favorite

Steady-State Pharmacokinetics of Gabapentin after Administration of a Novel Gastroretentive Extended-Release Formulation in Postmenopausal Women with Vasomotor Symptoms

By Cowles Verne E.  

Clinical Drug Investigation, Vol. 32, Iss. 9, 2012-09 ,pp. : 593-601

Adis International

Access to resources Recommend Favorite

Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet

By Wei Qionghua   Yang Feifei   Luan Libiao  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 6, 2013-06 ,pp. : 928-934

Informa Healthcare

Access to resources Recommend Favorite